Related Experiment Video
Updated: May 15, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Identification of a multistate continuous-time nonhomogeneous Markov chain model for patients with decreased renal
Alexander Begun1, Andrea Icks, Regina Waldeyer
1Institute of Biometrics and Epidemiology, German Diabetes Center at Heinrich-Heine-University, Düsseldorf, Germany. alexander.begun@ddz.uni-duesseldorf.de
Objectives:
Markov chain models are frequently used to study the clinical course of chronic diseases. The aim of this article is to adopt statistical methods to describe the time dynamics of chronically ill patients when 2 kinds of data sets--fully and partially observable data are available.
Model:
We propose a 6-state continuous-time Markov chain model for the progression of chronic kidney disease (CKD), where little is known about the transitions between the disease stages. States 1 to 3 of the model correspond to stages III to V of chronic kidney disease in the Kidney Disease Outcomes Quality Initiative (KDOQI) CKD classification. States 4 and 5 relate to dialysis and transplantation (renal replacement therapy), respectively. Death is the (absorbing) state 6.
Methods And Data:
The model can be investigated and identified using Kolmogorov's forward equations and the methods of survival analysis. Age dependency, covariates in the form of the Cox regression, and unobservable risks of transition (frailties) can be included in the model. We applied our model to a data set consisting of all 2097 patients from all renal centers in a region in North Rhine-Westphalia (Germany) in 2005-2010.
Results:
We compared transitions and relative risks to the few data published and found them to be reasonable. For example, patients with diabetes had a significantly higher risk for disease progression compared with patients without diabetes.
Conclusions:
In summary, modeling may help to quantify disease progression and its predictors when only partially observable prospective data are available.
Related Concept Videos
Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
